Comparing the risk of anaphylaxis requiring epinephrine in oral immunotherapy and subcutaneous immunotherapy: A review of recent Canadian real-world literature

Background: The safety of pediatric food oral immunotherapy (Ped-OIT) has been depicted by some as less favorable than subcutaneous immunotherapy (SCIT) owing to the increased number of serious adverse events requiring epinephrine. A review of real-world data comparing Ped-OIT and SCIT safety is nec...

Full description

Bibliographic Details
Main Authors: Uliana Kovaltchouk, MD, FRCPC, Samira Jeimy, MD, PhD, FRCPC, Lianne Soller, PhD, Kara Robertson, MD, FRCPC, Elissa M. Abrams, MD, FRCPC, Scott B. Cameron, MD, PhD, FRCPC, Harold Kim, MD, FRCPC, Edmond S. Chan, MD, FRCPC
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:Journal of Allergy and Clinical Immunology: Global
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S277282932300005X